- Home
- KURA vs PDFS Comparison
KURA vs PDFS Comparison
Compare KURA & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KURA | PDFS |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United States | United States |
| Employees | N/A | 600 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.8B |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | KURA | PDFS |
|---|---|---|
| Price | $11.73 | $44.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | $25.56 | ★ $39.67 |
| AVG Volume (30 Days) | ★ 2.0M | 604.4K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | $22.13 |
| Revenue Next Year | $106.37 | $18.92 |
| P/E Ratio | ★ N/A | $198.77 |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $7.36 | $21.96 |
| 52 Week High | $13.90 | $71.69 |
Technical Indicators
Market Signals| Indicator | KURA | PDFS |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 45.29 |
| Support Level | $8.45 | $43.00 |
| Resistance Level | $12.22 | $50.62 |
| Average True Range (ATR) | 0.48 | 2.16 |
| MACD | -0.20 | 0.02 |
| Stochastic Oscillator | 29.98 | 38.69 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About PDFS PDF Solutions Inc.
PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.